TITLE

Puny proteins predict breast cancer risk

AUTHOR(S)
Berger, Abi
PUB. DATE
June 1995
SOURCE
New Scientist;6/10/95, Vol. 146 Issue 1981, p16
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on Frans Hogervorst and colleagues at the University of Leiden in Holland's development of screening tests to detect the gene, BRCA1, which is responsible for half of all inherited breast tumors. Prior use of the tests in detecting Duchenne muscular dystrophy causing genes; Polymerase chain reaction use to amplify DNA sequence; Emphasis on exon 11 coding sequence.
ACCESSION #
9507105155

 

Related Articles

  • Finally, a peace dividend (and from the embattled CIA, no less). Adams, Kathleen; Barrett, Robertson // Time;10/17/1994, Vol. 144 Issue 16, p17 

    Reveals that sensitive technologies used by the CIA and Defense Department will now be adapted to spot breast tumors. The highly classified imaging techniques are about ten years ahead of medical imaging, according to Dr. Susan Blumenthal, deputy Assistant Secretary of Health and Human Services.

  • Breast-cancer test. Dreisbach, Shaun // Working Mother;Dec96, p12 

    Reports on the Food and Drug Administration's (FDA) approval of the High Definition Imaging (HDI) ultrasound method for more accurately determining whether breast lumps revealed by mammograms should be biopsied. Contrast to mammograms; Testing conducted by the FDA of the HDI; Drawback to the HDI.

  • Breast cancer: Needle core biopsy is your first diagnostic choice.  // Geriatrics;Sep94, Vol. 49 Issue 9, p16 

    States that needle core biopsy is the diagnostic technique of choice for most suspicious breast lumps because of its relative accuracy and safety. Recovery time; Drawbacks; Recommendations to ensure proper breast cancer screening and diagnosis.

  • FEA goes to the doctor's. Mahoney, Diana Phillips // Computer Graphics World;Jan97, Vol. 20 Issue 1, p59 

    Reports that researchers at the University of Texas Medical Center in Houston are using the finite element analysis (FEA) software from Algor to aid in their development of a new type of medical imaging modality for detecting tumors in breast tissue. Features of elastogram imaging technology.

  • The revolution in breast biopsy: Where is the surgeon? Israel, Philip Z. // American Surgeon;Feb1996, Vol. 62 Issue 2, p93 

    States the breast cancer is the most comment cause of death in American women. How can it be detected; Side affects; Experience at breast center.

  • ForeCYTE test like Pap smear for breast cancer. PEDERSEN, AMANDA // Medical Device Daily;2/20/2013, Vol. 17 Issue 34, p1 

    The article reports on healthcare firm Atossa Genetics Inc.'s ForeCYTE breast health test. It mentions its aim in detecting earlier signs of breast cancer as well as its application of the breast pump, Mammary Aspirate Specimen Cytology Test (MASCT), to collect small amount of fluid from breast...

  • Too much mammography. Kalager, Mette; Adami, Hans-Olov; Bretthauer, Michael // BMJ: British Medical Journal;2/15/2014, Vol. 348 Issue 7945, p8 

    The authors discuss the follow-up to the Canadian National Breast Screening Study published within the issue. They report the 22 percent overdiagnosis in the annual mammography screenings performed and the lack of change in breast cancer mortality recorded. They explore topics including the...

  • The harms and benefits of modern screening mammography. Elmore, Joann G.; Harris, Russell P. // BMJ: British Medical Journal;6/21/2014, Vol. 348 Issue 7963, p9 

    The authors discuss the harms and benefits of mammography screening in which the benefits have been shown to be insignificant while harms are substantial. They cite as basis studies from various sources such as the Independent United Kingdom Panel on Breast Cancer Screening, the Canadian...

  • Experts question IARC report that said benefits of mammography outweigh risks. Mayor, Susan // BMJ: British Medical Journal;6/13/2015, Vol. 350 Issue 8012, ph3156 

    The article looks at questions raised by experts over a summary report on breast screening from the World Health Organization's International Agency for Research on Cancer which said that the benefits of mammography outweighed the risks for women who are 50 to 74 years old.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics